Changes in weight after switching to dolutegravir containing antiretroviral therapy in the Swiss HIV cohort study

被引：0
|
作者：
Mugglin, C. [1 ]
Calmy, A. [2 ]
Guenthard, H. [3 ]
Tarr, P. [4 ]
Atkinson, A. [1 ]
Scherrer, A. [5 ,6 ]
Cavassini, M. [7 ,8 ]
Marzolini, C. [9 ,10 ,11 ]
Schmid, P. [12 ]
Bernasconi, E. [13 ]
Braun, D. [5 ,6 ]
Wandeler, G. [1 ]
Rauch, A. [1 ]
机构：
[1] Univ Bern, Bern Univ Hosp, Dept Infect Dis, Bern, Switzerland
[2] Geneva Univ Hosp, Div Infect Dis, Geneva, Switzerland
[3] Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[4] Univ Basel, Kantonsspital Baselland, Dept Med & Infect Dis Serv, Bruderholz, Switzerland
[5] Univ Hosp Zurich, Zurich, Switzerland
[6] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[7] Lausanne Univ Hosp, Lausanne, Switzerland
[8] Univ Lausanne, Serv Infect Dis, Lausanne, Switzerland
[9] Univ Hosp Basel, Basel, Switzerland
[10] Univ Basel, Dept Med, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland
[11] Univ Basel, Dept Clin Res, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland
[12] Cantonal Hosp St Gallen, Div Infect Dis & Hosp Epidemiol, St Gallen, Switzerland
[13] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PS3/5
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006
    Nguyen, A.
    Calmy, A.
    Schiffer, V.
    Bernasconi, E.
    Battegay, M.
    Opravil, M.
    Evison, J-M
    Tarr, P. E.
    Schmid, P.
    Perneger, T.
    Hirschel, B.
    HIV MEDICINE, 2008, 9 (03) : 142 - 150
  • [32] Effect of dolutegravir on weight changes and lipid profile compared with efavirenz in people living with HIV: A retrospective cohort study
    Setpakdee, Rachawit
    Kiertiburanakul, Sasisopin
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2025, 18 (02)
  • [33] Weight gain in Namibians with HIV switching from efavirenz to dolutegravir
    Hachey, David
    van Woerden, Irene
    Shiluama, Roselli
    Singu, Bonifasius Siyuka
    INTERNATIONAL JOURNAL OF STD & AIDS, 2023, 34 (12) : 854 - 859
  • [34] Severe Thrombocytopenia During Dolutegravir-containing Antiretroviral Therapy
    Nakaharai, Kazuhiko
    Miyajima, Makiko
    Kobayashi, Hiroaki
    Shimizu, Akihiro
    Hosaka, Yumiko
    Horino, Tetsuya
    Hori, Seiji
    INTERNAL MEDICINE, 2017, 56 (16) : 2229 - 2232
  • [35] Weight, Anthropometric and Metabolic Changes After Discontinuing Antiretroviral Therapy Containing Tenofovir Alafenamide (TAF) in People With Human Immunodeficiency Virus (HIV)
    Damas, Jose
    Munting, Aline
    Fellay, Jacques
    Haerry, David
    Marzolini, Catia
    Tarr, Philip E.
    Steffen, Ana
    Braun, Dominique L.
    Stoeckle, Marcel
    Bernasconi, Enos
    Tshikung, Olivier Nawej
    Fux, Christoph A.
    Darling, Katharine E. A.
    Beguelin, Charles
    Wandeler, Gilles
    Cavassini, Matthias
    Surial, Bernard
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 990 - 998
  • [36] Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study
    Castillo-Mancilla, Jose R.
    Cavassini, Matthias
    Schneider, Marie Paule
    Furrer, Hansjakob
    Calmy, Alexandra
    Battegay, Manuel
    Scanferla, Giulia
    Bernasconi, Enos
    Gunthard, Huldrych F.
    Glass, Tracy R.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (02):
  • [37] Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study
    Mendes Pereira, Gerson Fernando
    Kim, Ahra
    Jalil, Emilia M.
    Fonseca, Fernanda Fernandes
    Shepherd, Bryan E.
    Veloso, Valdilea G.
    Rick, Fernanda
    Ribeiro, Rachel
    Pimenta, Maria Cristina
    Beber, Andrea
    Correa, Renato Girade
    Lima, Renato
    Maruri, Fernanda
    McGowan, Catherine C.
    Benzaken, Adele Schwartz
    Grinsztejn, Beatriz
    Castilho, Jessica L.
    LANCET HIV, 2021, 8 (01): : e33 - e41
  • [38] Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy
    Griesel, Rulan
    Kawuma, Aida N.
    Wasmann, Roeland
    Sokhela, Simiso
    Akpomiemie, Godspower
    Venter, W. D. Francois
    Wiesner, Lubbe
    Denti, Paolo
    Sinxadi, Phumla
    Maartens, Gary
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 883 - 893
  • [39] Hyperglycemia After Dolutegravir-Based Antiretroviral Therapy
    Hailu, Workagegnehu
    Tesfaye, Tsebaot
    Tadesse, Abilo
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 503 - 507
  • [40] A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
    Wandeler, Gilles
    Keiser, Olivia
    Hirschel, Bernard
    Guenthard, Huldrych F.
    Bernasconi, Enos
    Battegay, Manuel
    Clerc, Olivier
    Vernazza, Pietro L.
    Furrer, Hansjakob
    PLOS ONE, 2011, 6 (12):
12345